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We tested the hypothesis that TAG accumulation in the liver induced by short-term high-fat diet (HFD) in rats leads to the
dysregulation of endogenous TAG degradation by lysosomal lipase (LIPA) via lysosomal pathway and is causally linked with
the onset of hepatic insulin resistance. We found that LIPA could be translocated between qualitatively diﬀerent depots (light
and dense lysosomes). In contrast to dense lysosomal fraction, LIPA associated with light lysosomes exhibits high activity on
both intracellular TAG and exogenous substrate and prandial- or diet-dependent regulation. On standard diet, LIPA activity
was upregulated in fasted and downregulated in fed animals. In the HFD group, we demonstrated an increased TAG content,
elevated LIPA activity, enhanced production of diacylglycerol, and the abolishment of prandial-dependent LIPA regulation in
light lysosomal fraction. The impairment of insulin signalling and increased activation of PKCε was found in liver of HFD-fed
animals. Lipolysis of intracellular TAG, mediated by LIPA, is increased in steatosis probably due to the enhanced formation of
phagolysosomes. Consequent overproduction of diacylglycerol may represent the causal link between HFD-induced hepatic TAG
accumulation and hepatic insulin resistance via PKCε activation.
1.Introduction
NAFLD (nonalcoholic fatty liver disease) is often associated
with insulin resistance (IR) and type 2 diabetes [1]. High-fat
diet-inducedlivertriacylglycerol(TAG)accumulationresults
in the hepatic IR even after three days of administration
and without signiﬁcant impairment of insulin-mediated
peripheral glucose disposal [2]. However, the mechanism by
which hepatic fat accumulation might lead to the hepatic
insulin resistance is far from being clearly understood [3].
The TAG metabolism in the liver is subject to a highly
sensitive regulation in order to fulﬁl the actual needs of
the organism. It has been shown that the liver is a site
of continuous lipolysis of endogenous TAG and partial
reesteriﬁcation of released free fatty acids (FFA) back to the
intracellular lipid storage pool [4]. The rate of intracellular
lipolysis is 2-3 times greater than required to maintain the
observed rate of TAG secretion [5].
Nevertheless, in spite of intensive research in this ﬁeld,
there are many uncertainties concerning the enzyme(s)
responsible for intracellular TAG degradation. One possible
candidateislysosomallipase(LIPA)[6].Itbelongstoagroup
of more than 50 acid hydrolases that are characterised by
low pH optimum (4.5–5). Because these enzymes require a
pH range that is incompatible with the neutral cytoplasma
milieu, they are sequestered in speciﬁc cytoplasmic particles2 Biochemistry Research International
termed lysosomes [7]. Due to a large variety of lysosomal
enzymes (including proteases, lipases, glycosidases, and
nucleases), lysosomes mediate complete breakdown of many
types of molecules and confer upon this organelle its high
degradative capacity [8]. Lysosomal enzymes are synthe-
sized in endoplasmic reticulum, sequestered into specialised
regions of Golgi apparatus, and bud out and detach as
small vesicles called primary lysosomes [9]. Substrates can
reach lysosomes via heterophagy (including exocytosis and
phagocytosis), in which cargo originates at the plasma
membrane or extracellularly, or via autophagy, for cargo
located in the cytosol. Material designed for degradation is
temporally stored in digestively inactive organelles termed
phagosomes. Only after fusion of phagosome with primary
lysosome and acidiﬁcation of intralysosomal space could
the internalized material be degraded and the degradation
products released back into cytoplasm [10]. The lysosomal
pathway was originally associated with removal of organelles
and degradation of proteins [11]. Only recently the critical
role of this pathway in metabolism and storage of intra-
cellular lipids has been discovered [12]. Hayase and Tappel
[13] showed that lysosomal lipase is capable of hydrolyzing
triacylglycerols and that the dominant products of lysosomal
lipase action on TAG molecule are diacylglycerol (DAG) and
one molecule of fatty acid. DAG is a known activator of
classic and novel isoforms of protein kinase C (PKC), and
DAGconcentrationshavecloselyparalleledinsulinresistance
in other models [14, 15]. While PKCs, in general, have been
implicated in the pathogenesis of insulin resistance in many
tissues, Samuel et al. [16, 17] delineated the speciﬁc role of
one particular isoform, PKCε, in the development of fat-
induced insulin resistance in the liver.
We hypothesized that steatosis-associated hepatic IR is
causally linked with alteration of endogenous TAG degrada-
tion in NAFLD. To address this issue, the activity of LIPA
and the production of TAG breakdown intermediates were
determined in animals with normal insulin sensitivity and
with hepatic IR induced by a two-week administration of a
high-fat diet. We identiﬁed the steatosis-associated changes
intheregulationofLIPAactivitybasedonthealterationinits
intracellular distribution, and we proposed the mechanism
by which it can contribute to the establishment of hepatic IR.
2.MaterialsandMethods
2.1. Animals and Experimental Protocol. Male rats were
kept in temperature-controlled room at 12:12 h light-dark
cycle. Animals had free access to drinking water and diet
if not stated otherwise. All experiments were performed in
agreement with the Animal Protection Law of the Czech
Republic 311/1997 which is in compliance with Principles of
LaboratoryAnimalCare(NIHpublicationno.85-23,revised
1985) and were approved by the ethical committee of the
Institute for Clinical and Experimental Medicine. Starting
at age 3 months (b.wt. 300 ± 2 0 g ) ,a l la n i m a l sw e r ef e d
either HFD (70cal% as saturated fat, 20cal% as protein, and
10cal% as carbohydrate) or standard laboratory chow diet
(SD) for 2 weeks. The groups labelled SD fed or HFD fed
had free access to the diet until decapitation (10–11am),
and the groups designated as SD fasted or HFD fasted were
deprived of food for the last 24 hours. Glucose tolerance
was determined as the rate of disappearance of glucose
from circulation after a single dose of glucose (3g/kg b.wt.)
administered intragastrically to overnight-fasted animals.
2.2. Preparation of Lysosomal and Phagolysosomal Fractions.
The lysosomes and phagolysosomes represent a heteroge-
neous population of organelles. 20% (wt/vol) homogenate
was prepared by homogenization of liver tissue in 0.25M
sucrose; 0.001M EDTA pH = 7.4; heparin 7IU/m, 1mM
PMSF, leupeptin 10μg/mL, and aprotinin 10μg/mL by
Teﬂon pestle homogenizer. The crude impurities were
removed by brief centrifugation at 850g. The fat cake was
removed carefully in order to prevent contamination of
liquid fraction. An aliquot of the homogenate was kept
at 4◦C until lipase assay (maximum 2 hour), the rest was
centrifuged for 10 000g 20min 4◦C, and the resulting pellet
and supernatant were separated. The supernatant contains
preferentially the less dense lysosomes with higher TAG
content (light lysosomes), and the pellet is formed by more
dense particles (dense lysosomes).
2.3. Assay of Triacylglycerol Lipase Activity on Exogenous Sub-
strate. The optimal conditions for the lipase assay (substrate
concentration, reaction temperature, and linear range of the
assay) were determined in the pilot experiments. The data
are provided in supplements (a–c). 4% liver homogenate or
lysosomal subfractions prepared from the fresh tissue under
iso-osmotic conditions were used for the assay. The reaction
medium (92.5kBq 3H triolein, 100μM triolein, 110μM
lecithin, 0.15M NaCl, and 0.1M acetate buﬀer pH 4.5) was
emulsiﬁed by sonication (Hielsler sonicator UP200S). The
assay itself was performed under hypoosmotic conditions
(50mM sucrose) in order to ensure the release of the enzyme
sequestered within the lysosomes. The liver homogenate or
isolated fractions were incubated for 60 minutes at 30◦C.
The released fatty acids were extracted according to [18]a n d
counted for radioactivity.
2.4. Assay of Triglyceride Lipase Activity on Endogenous
Substrate. This approach takes advantage of the coordinated
changes in the intracellular localisation of LIPA and its
intracellular substrate. The optimal conditions for the lipase
assay were determined in the pilot experiments. The data
are provided in supplements (e, f). The liver homogenate
a n ds u b c e l l u l a rf r a c t i o n sw e r ep r e p a r e da sd e s c r i b e da b o v e
under iso-osmotic conditions that prevent the disruption of
lysosomes. The lysis of lysosomes was induced only after
separation of fractions during the assay. 20% homogenate
was mixed 1:1 with 0.2M acetate buﬀer pH = 4.5 and
incubated for 60min in 30◦C in shaking water bath. The
reactionmixturewasextractedinchloroform-methanol,and
p h a s e sw e r es e p a r a t e db y1MN a C l .
Aliquots of lower chlorophorm phase were separated
for further determination of FFA and DAG content. An
aliquot of chlorophorm phase was evaporated, and 100μLBiochemistry Research International 3
of Krebs-Ringer phosphate buﬀer (pH = 7.6) containing
6% FFA-free BSA was added. The tubes were incubated in
shaking incubator at 37◦C for 2 hours. FFA concentration
in ﬁnal KRF/BSA solution was measured using commercially
available kit. In order to check the eﬃciency of FFA
solubilisation, the emptied tubes were washed with fresh
KRB+6% BSA, and then 100μL of chlorophorm was added.
An aliquot was separated by TLC, but no substantial traces of
F F Aw e r ed e t e c t e d .
2.5. Determination of DAG Content. This method is based
on the phosphorylation of DAG in the sample to DAG-
3-phosphate using γ35-ATP followed by quantiﬁcation of
radioactivity in a chlorophorm extract. Lipids from liver
tissueorincubationmixturewereextractedinchlorophorm-
methanol and an aliquot of chlorophorm phase was evapo-
rated under the stream of nitrogen. The sample was than sol-
ubilisedbysonicationindetergentbuﬀer(7.5%n-octyl-β-D-
glucopyranoside, 5mM cardiolipin, and 1mM DETAPAC).
Reaction buﬀer (50mM imidazole/HCl, pH = 6.6, 50mM
NaCl, 12.5mM MgCl2, and 1mM EGTA), diacylglycerol
kinase, and γ35-ATP were added and incubated 30min in
25◦C. Lipids were extracted into chlorophorm-methanol,
phaseswereseparatedwith1%HCLO4,andtheexactvolume
of lower chlorophorm phase was determined. An aliquot
was evaporated, resolved in 5% chlorophorm-methanol, and
separated by TLC. Individual populations of lipids were
visualised by iodine vapours, the bands corresponding to
DAG were scraped oﬀ, and the radioactivity was determined
by scintillation counting.
2.6. Incubation of Liver Slices In Vitro. The production of β-
hydroxybutyratefromliverslicesinvitrowasmeasuredinthe
absence of exogenous FFA. Liver slices (width approximately
1mm) were quickly dissected and incubated for 2 hours in
Krebs Ringer bicarbonate buﬀer with 5mmol/L glucose, 2%
bovine serum albumin, gaseous phase 95% O2, and 5% CO2.
All incubations were carried out at 37◦C in sealed vials in a
shaking water bath. The aliquots of the incubation medium
were stored frozen until the further analysis.
2.7. Electrophoretic Separation and Immunodetection. The
homogenate, light lysosomal fraction, and dense lysosomal
fraction prepared as described above were used for the
assessment of LIPA protein content. A separate group of rats
were used to assess the impact of hepatic fat accumulation
on the insulin signalling pathway. The animals were either
deprived of food for 24 hours (fasted) or had free access to
food,andinsulin(6U/kgi.p.)wasadministered30minprior
decapitation (fed + insulin). Liver samples (200mg) were
harvested in situ and stored in liquid nitrogen until further
utilization. The homogenate was prepared by Ultra-Turax
homogenizer (IKA Worke, Staufen, Germany) in homoge-
nization buﬀer (150mM NaCl, 2mM EDTA, 50mM TRIS,
20mM glycerolphosphate, 1mM Na3VO4,2 m Ms o d i u m
pyrophosphate, 1mM PMSF, leupeptin 10μg/mL, and apro-
tinin 10μg / m L ) .T h eh o m o g e n a t ew a su s e df o rd e t e r m i n a -
tion of mTOR and Akt phosphorylation. The proteins were
separated by electrophoretic separation under denaturing
conditions and electroblotted onto PVDF membranes. The
level of phosphorylation of Akt and mTOR kinases was
assessed by immunodetection using speciﬁc phospho-Akt
(Ser473) antibody and phospho-mTOR (Ser2448) antibody,
respectively. The total expression of Akt and mTOR protein
was determined on the same membrane after striping and
reblotting using speciﬁc antibodies. All these antibodies were
purchased from Cell Signalling Technology, (Boston, MA).
The immunodetection of LIPA protein was performed using
mouse monoclonal (9G7F12) antibody to lysosomal acid
lipase (Abcam, Cambridge, UK). The loading control was
performed using rabbit polyclonal antibody to beta actin
(Abcam, Cambridge, UK). The bands were visualized using
ECL and quantiﬁed using FUJI LAS-3000 imager (FUJI
FILM, Japan) and Quantity One software (Biorad, Hercules,
CA).
2.8. PKC Membrane Translocation. The liver homogenate
was prepared as described above. The total membrane
and cytosolic fractions were prepared by centrifugation of
the homogenate at 100000g. Solubilisation of membrane
fraction was carried out in 1% Triton X-100, 0.1% SDS,
and 0.5% deoxycholate. After electrophoretic separation and
blotting, the PKCε was detected using anti-PKCε antibody
(Sigma, St. Louis, USA). PKC translocation was expressed
as the ratio of arbitrary units of membrane bands over the
cytosol bands.
2.9. Biochemical Analysis. TAG content in liver homogenate
or phagolysosomal fraction was determined after the extrac-
tion according to Folch et al. [19]. The glycogen content
was determined in fat-free dry mass after hydrolysis in 30%
KOHandexpressedasaglucoseequivalent(μmolespergdry
weight).
FFA, insulin, TAG and glucose serum content, and β-
hydroxybutyrate production were determined using com-
merciallyavailablekits(FFA:FFAhalfmicrotest,RocheDiag-
nostics GmbH Mannheim, Germany; triglycerides and glu-
cose: Pliva-Lachema, Brno CR; insulin: Mercodia, Uppsala,
Sweden; β-hydroxybutyrate: RanBut, RANDOX Crumlin,
UK).
2.10.StatisticalAnalysis. Dataarepresentedasmean ±SEM.
Statistical analysis was performed using Kruskal-Wallis test
with multiple comparisons (n = 5–7). Diﬀerences were
considered statistically signiﬁcant at the level of P<0.05.
3. Results
3.1. The Eﬀect of HFD on Physical and Metabolic Parameters.
The two-week period of HFD resulted in higher body weight
andincreasedfataccumulationdeterminedasepididymalfat
pad:body weight ratio (Table 1). The impairment of glucose
metabolism was indicated by increased fasting glycemia,
increased fasting insulinemia, and impaired glucose toler-
ance measured by oral glucose tolerance test and expressed
as AUC1–180 min. The alterations in glucose metabolism were4 Biochemistry Research International
Table 1: The eﬀect of HFD on physical and metabolic parameters.
Standard diet High-fat diet
Fasted Fed Fasted Fed
Body weight (g) 331 ±6.9 379 ±10.7x
Epididymal fat pad/b.w. (g/100g) 0.9 ±0.07 1 ±0.06 1.4 ±0.07
∗ 1.4 ±0.04#
Glycemia (mmol/L) 5.1 ±0.17 .9 ± 0.5+ 5.9 ±0.2
∗ 8.1 ±0.3+
Insulinemia (pmol/L) 56 ±15 135 ±21+ 125 ±10
∗ 127 ±18
AUC0–180 (mmol glucose/L) 1168 ±26.6 1325 ±32.9x
Serum Tg (mmol/L) 0.7 ±0.11 .4 ±0.08+ 0.7 ±0.02 1.4 ±0.1+
Serum FFA (mmol/L) 0.7 ±0.05 0.4 ±0.02+ 0.6 ±0.08 0.45 ±0.07+
ALT (μkat/L) 1.2 ±0.11 .2 ±0.1
AST (μkat/L) 4.3 ±0.63 .9 ±0.3
β-hydroxybutyrate (μmol/L) 1.67 ±0.05 0.05 ± 0.01+ 3.2 ±0.25
∗ 0.28 ±0.05#,+
Data are given as means ± SEM, n = 7. xP < 0.05 HFD versus SD group; +P < 0.05 fasted versus fed animals; ∗P < 0.05 SD- versus HFD-fasted animals;
#P < 0.05 SD- versus HFD-fed animals.
0
100
200
300
400
n
m
o
l
F
F
A
·
m
g
p
r
o
t
−
1
Homogenate
HFD SD
(a)
Dense lysosomes
0
100
200
300
400
n
m
o
l
F
F
A
·
m
g
p
r
o
t
−
1
HFD SD
(b)
0
100
200
300
400
n
m
o
l
F
F
A
·
m
g
p
r
o
t
−
1
HFD SD
Light lysosomes
##
++
(c)
Figure 1: The eﬀect of HFD on the LIPA activity measured as FFA release from artiﬁcial substrate (3H-triolein). (a) Homogenate; (b) dense
lysosomes; (c) light lysosomes. The lipase activity was measured as the release of fatty acids at pH = 4.5 from 3H-triolein. Open bars = fasted
animals; hatched bars = fed animals. ++P < 0.01 fed versus fasted; ##P < 0.01 HFD fed versus SD fed.Biochemistry Research International 5
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Figure 2: The eﬀect of HFD on the LIPA activity measured as FFA release from endogenous TAG. (a) Homogenate; (b) dense lysosomes;
(c) light lysosomes. 10% liver homogenate, light or dense lysosomal fraction were incubated 60min at pH = 4.5. At the end of incubation,
the released FFAs were quantiﬁed as described in Section 2. The graph shows the diﬀerence between FFA concentration in the sample at the
beginning and atthe end ofthe incubation. Open bars = fastedanimal; hatched bars = fed animals. +++P < 0.001 fed versus fasted;
∗P < 0.05
HFD fasted versus SD fasted; #P < 0.05, ##P < 0.01 HFD fed versus SD fed.
not accompanied by dyslipidemia. Serumβ-hydroxybutyrate
concentration was signiﬁcantly elevated in both HFD-fed as
well as HFD-fasted group compared to corresponding SD
groups what indicates increased utilisation of fatty acids for
ketogenesis in the liver. Short-term HFD administration did
not alter ALT and AST serum concentrations.
As expected, compared to the SD group, the HFD-
administeredanimalsaccumulatedincreasedamountofTAG
(fasted: 14.6 ± 1.4v e r s u s3 .2 ± 0.2; P<0.001; fed: 16.2 ± 2.5
versus 2.9±0.2μmol/g;P<0.001)andDAG(fasted:138±17
versus 83 ±12; P<0.01; fed: 145 ±19 versus 53 ±9n m o l / g ;
P<0.001) in the liver. The insulin-stimulated increase of
glycogen content in liver was lower in HFD compared to SD
animals (fasted: 27±7v e r s u s4 1±9n.s.; fed: 123±10 versus
261 ±15μmol/g; P<0.001).
3.2. The Eﬀect of HFD on Lysosomal Lipase Activity. In order
to determine maximal LIPA activity in liver homogenate
and in particular lysosomal subpopulations, we employed
emulsiﬁed 3H-labeled triolein as a substrate. In this exper-
imental setting, the substrate is present in excess, and the
only limiting factor is the amount of enzyme. The total
LIPA activity measured in the whole homogenate was not
aﬀected either by prandial status (fasted or fed state) or
diet intervention (SD or HFD) (Figure 1(a)). Similar results
were observed in the fraction of dense lysosomes that
represent primary lysosomes (Figure 1(b)). On 3H-triolein
as a substrate, we found most of total LIPA activity in this
fraction. The LIPA activity determined in light lysosomes
represents only minor portion of total activity, but unlike
homogenate or dense lysosomes, it responds to diﬀerent
metabolic states (Figure 1(c)). In the SD group, it is elevated
in fasting and depressed in fed state. HFD feeding abolished
the prandial regulation of LIPA activity especially due to its
upregulation in fed state.
A separate set of experiment was designed in order to
evaluate the contribution of LIPA associated with dense and6 Biochemistry Research International
SD HFD
SD HFD
Homogenate
(
a
.
u
)
LIPA
Actin
Fasted Fed Fasted Fed
0
2
4
6
8
10
12
14
(a)
Dense lysosomes
SD HFD
LIPA
Actin
Fasted Fed Fasted Fed
SD HFD
(
a
.
u
)
0
2
4
6
8
10
12
14
(b)
Light lysosomes
##
++
SD HFD
(
a
.
u
)
0
2
4
6
8
10
12
14
SD HFD
LIPA
Actin
Fasted Fed Fasted Fed
(c)
Figure 3: The eﬀect of HFD on the LIPA protein expression. (a) Homogenate; (b) dense lysosomes; (c) light lysosomes. Representative
Western blots are shown above each graph (f = fasted, F = fed). The results are expressed as arbitrary units after normalisation to the actin
expression (loading control). Open bars = fasted animals; hatched bars = fed animals. ++P < 0.01 fed versus fasted; ##P < 0.01 HFD fed
versus SD fed.
light lysosomes to the degradation of intracellular TAG. In
this experimental design, the intracellular TAGs contained
in particular fraction are the only source of substrate, and
the intensity of lipolysis depends not only on the amount
of enzyme but also on the amount of substrate available in
the sample (Figures 2(a), 2(b),a n d2(c)). Compared with
the same experiments carried on 3H-triolein, we found two
diﬀerences. First, HFD administration led to a signiﬁcant
increase of total LIPA activity measured in homogenate.
Second, after separation of lysosomal subpopulations, LIPA
activityassociatedwithlightlysosomeswashigherthanthose
associated with dense lysosomes. This observation could be
explained by the previous “in vivo” translocation of both
the substrate (TAG droplets) and the enzyme (LIPA) into
light lysosomal fraction (phagolysosomes). In accordance
with this presumption, we found higher TAG content in
phagolysosomal fraction in HFD compared with SD group
(fasted: 2.3±0.2v e r s u s4 .1±0.7; fed: 1.02±0.3v e r s u s5 .6±
0.48μmol·mgprot−1). Similarly with the results obtained
on 3H-triolein, the eﬀect of fasting was manifested only
in SD group and only in light lysosomal fraction. HFD
feeding resulted into the elevation of LIPA activity in light
lysosomes and into the abolishment of prandial regulation.
Taken together, our results indicate that in the liver most of
the enzyme is present in inactive form in dense (primary)
lysosomes, and the physiologically active portion of the
enzyme could be determined in light lysosomal fraction.
3.3. The Eﬀect of HFD on Lysosomal Lipase Protein Distri-
bution. In order to distinguish whether the higher LIPA
activity found in the light lysosomal fraction in HFD
group is consequent to the increased amount of enzyme
in this fraction or only to the increased availability of the
substrate, we determined the amount of LIPA protein in
liver homogenate and in particular fractions. We found that
the LIPA protein content in homogenate (Figure 3(a))a n d
dense lysosomal fraction (Figure 3(b)) is similar in both
fasted and fed animals and that it is not aﬀected by short-
term HFD administration. In contrast to these ﬁndings, the
abundance of LIPA protein in light lysosomal fraction is
lower than in homogenate or dense lysosomes, but it varies
according to several factors (Figure 3(c)). In SD group, it
strongly depends on prandial status. In SD-fasted rats, LIPA
protein abundance in this fraction is signiﬁcantly higher
compared with their fed counterparts. Short-term HFD diet
has no eﬀect on the content of LIPA protein in fasted
animals, but it signiﬁcantly increases its amount in the fed
ones. Consequently, the prandial-dependent regulation is
completely abolished in HFD group.
3.4. Diacylglycerol Production in Incubated Liver Homogenate.
DAG is one of the major products of LIPA action on
TAG molecule as this enzyme has lower aﬃnity to DAG
or monoacylglycerol compared with its aﬃnity to TAG
[13]. In our experimental conditions (incubation of liver
homogenateorisolatedfractioninpH =4.5),DAGcouldnot
be further utilised for TAG biosynthesis, and the diﬀerence
in DAG concentrations at the end and at the beginning
of incubation represents the net DAG production from
TAG degradation. Nevertheless, we cannot exclude someBiochemistry Research International 7
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Figure 4: The eﬀect of HFD on the DAG production from intracellular TAG in vitro. (a) Homogenates; (b) dense lysosomes; (c) light
lysosomes. 10% liver homogenate, dense lysosomal or light lysosomal fractions were incubated 60min at pH = 4.5. At the end of incubation,
DAG was extracted into chlorophorm-methanol and quantiﬁed as described in Section 2. The graph shows the diﬀerence between DAG
concentration in the sample at the beginning and at the end of the incubation. Open bars = fasted animals; hatched bars = fed animals.
+P < 0.05 fed versus fasted;
∗P < 0.05,
∗∗P < 0.01 HFD fasted versus SD fasted; #P < 0.05, ##P < 0.01 HFD fed versus SD fed.
degradation of DAG by lysosomal carboxylesterases. In
homogenate, DAG production in SD group was signiﬁcantly
lower compared with those in HFD, and it was prandial
dependent, that is, elevated in fasting and downregulated in
fed state. In HFD group, a signiﬁcant DAG production was
detected in both fasted and fed animals (Figure 4(a)). The
stimulatory eﬀect of HFD on DAG production was found in
both dense (Figure 4(b))a n dl i g h t( Figure 4(c))l y s o s o m e s .
In HFD group, approximately 60% of DAG formation
occurred in light lysosomal fraction, and in contrast to the
SD group, it was independent of prandial status.
3.5. The Eﬀect of HFD on Ketogenesis In Vitro. LIPA is
expressed not only in hepatocytes but also in many other
cell types including Kupﬀer cells present in the liver. In
order to address the issue whether the above-mentioned
changes in LIPA activity could be ascribed to hepatocytes, we
measured ketone bodies production from liver slices in vitro
(Figure 5). Ketogenesis is the metabolic pathway occurring
exclusivelyinhepatocytesandtightlyreﬂectstheintracellular
T A Gm e t a b o l i s m .W ef o u n da ne l e v a t e dk e t o g e n e s i sd u et o
the HFD administration what under these experimental set
up implicates the accentuation of TAG hydrolysis. When
liver slices were incubated in the absence of exogenous
FFA, HFD-fasted group exhibited signiﬁcantly higher β-
hydroxybutyrate production compared with SD fasted. A
similar trend was found also in fed animals.
3.6.TheEﬀectofHFDonKeyComponentsofInsulinSignalling
Pathway. To determine the eﬀect of HFD on hepatic insulin
sensitivity, the activation of key components of insulin
signalling pathway was measured by immunodetection of
their phosphorylation status. As shown in Figure 6(a), the
insulin-stimulated phosphorylation of Akt kinase was sig-
niﬁcantly impaired in HFD-compared to SD group. Similar8 Biochemistry Research International
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results were obtained for mTOR (Figure 6(b)) suggesting an
impairment of insulin signal transduction.
3.7. The Eﬀect of HFD on PKCε Activity. Determination of
the relative abundance of the particular PKC isoform in the
membrane and cytosol fractions reﬂects PKCε activation. An
increase in the membrane to cytosol fraction ratio was used
as an indicator of PKCε activation. As shown in Figure 7,
PKCε was signiﬁcantly activated in the liver of the HFD-
administered animals.
4. Discussion
In the present study, we provide evidence that in steatosis
the increased degradation of TAG mediated by LIPA and
associated with the increased production of DAG may be
one of the mechanisms determining the rapid onset of
hepatic IR. Our hypothesis is based on following ﬁndings.
First, alterations in LIPA activity associated with diﬀerent
metabolic states are based on prandial-dependent transloca-
tion of the enzyme from the inactive pool of dense lysosomes
into light lysosomal fraction, and it is upregulated in fasting
and downregulated in the fed state. After short-term HFD
administration, this prandial-dependent regulation of LIPA
activity is abolished. The fed state-associated downregula-
tion of LIPA activity is impaired, and the portion of the
active enzyme is permanently increased. These changes were
demonstrated on both endogenous TAG and exogenous
substrate (emulsiﬁed 3H-triolein). Second, in steatosis, the
production of TAG degradation intermediates, FFA and
DAG, by lysosomal lipase was signiﬁcantly elevated. Finally,
we proved an increased PKCε activation together with the
defects in the insulin-signalling cascade in the fatty liver.
Taken together, these data indicate that the enhanced activity
ofLIPAinHFD-fedanimalsandfollowingoverproductionof
PKCεactivatorDAGcontributetotheestablishmentofHFD-
induced IR. We have previously shown that LIPA is involved
in the degradation of intracellular TAG in the liver [20]. The
essential role of LIPA for hydrolysis of TAG is supported by
ﬁndings of Du et al. [21] who reported that LIPA knock-out
mice (Lipa −/−) exhibited progressive hepatosplenomegaly
and massive TAG accumulation in the liver.
Our data indicate that the principal factor regulating
the LIPA activity is not the total amount of the enzyme
itself but rather its intracellular localisation. We did not
ﬁnd any signiﬁcant diﬀe r e n c e si nL I P Am R N Ae x p r e s s i o n
in response to either fasting or diet intervention (not
shown), and in accordance with this, we did not ﬁnd any
diﬀerence in total LIPA protein content determined in the
whole homogenate. According to Seglen and Solheim [22],
active phagolysosomes have a lower density than the small,
inactive lysosomes, allowing their separation by diﬀerential
centrifugation. Based on this observation, we separated the
total lysosomes into two subpopulations according to their
density.Weexpectedthattheactivelysosomescontainingthe
TAG substrate would remain in the less dense fraction (light
lysosomes), while the inactive lysosomes would sediment
(dense lysosomes). In our experimental setting, the eﬀect
of fasting or HFD was manifested predominantly in light
lysosomal fraction what supports the physiological relevance
of this methodology. In SD group, we observed a signif-
icant prandial-dependent regulation, LIPA activity being
upregulated in fasted and downregulated in fed animals.
HFD feeding was associated with a signiﬁcant elevation of
LIPA protein content and LIPA activity in light lysosomal
fraction particularly in fed animals and consequently with
the abolishment of prandial-dependent regulation of LIPA
activity. Similar trends were observed on both exo- and
endogenous substrates. The changes in LIPA activity were
reﬂected by the corresponding changes in LIPA protein con-
tent in light lysosomal fraction. The interesting conclusions
come from the comparison of LIPA activity in the light and
dense lysosomal fractions determined on either 3H-triolein
or intracellular TAG. The activity measured on 3H-triolein
depends only on the amount of the enzyme present in the
particular fraction as the substrate is available in excess. In
contrast, when intracellular TAGs are the only source of
substrate, the activity in particular fractions depends on the
coordinated translocation of the enzyme and the substrate.
The main diﬀerence in LIPA activity determined by these
two approaches was found in the distribution of LIPA
activity among dense and light lysosomal fractions. In dense
lysosomes, we found high LIPA activity on 3H-triolein but
only low LIPA activity on intracellular TAG. This diﬀerence
indicates that dense lysosomal fraction contains an enzyme
that is not active in physiological situation but that could be
activated after addition of the arteﬁcial substrate. The LIPA
activity determined in light lysosomes represented the bulk
of total LIPA activity on intracellular TAG substrate but only
minor portion of total activity determined on 3H-triolein. It
is possible to speculate that the LIPA activity on endogenous
substrate quantitatively reﬂects the formation of activated
lysosomes, that is particles containing both the substrate and
the enzyme. Taken together, these data indicate that LIPABiochemistry Research International 9
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Figure 6: Alterations of insulin signalling cascade associated with hepatic fat accumulation. All results are expressed as a fold increase in the
insulin-stimulatedstaterelativetothebasalstate.RepresentativeWesternblotsareshownaboveeachgraph.(a)FoldincreaseinAkt(Ser473)
phosphorylation, (b) fold increase in mTOR (Ser2448) phosphorylation. The basal level of protein phosphorylation was determined in the
homogenate prepared from the liver of 24 hours fasted animals. The eﬀect of insulin was determined in identically processed samples from
animals which had free access to food and 40min prior to decapitation were administered insulin 6U/kg. The total protein (Akt or mTOR)
expression was determined after striping the membrane and reblotting with anti-Akt or anti-mTOR antibody. Values represent means ±
S.E.M. of 7 animals. xP < 0.05.
associatedwithlightlysosomesrepresentsthephysiologically
active enzyme.
We suppose that in NAFLD, characterised by high TAG
intracellular content, one of the factors determining the
phagolysosomal formation may be the substrate availability
itself. The increased amount of intracellular lipid droplets
in steatosis could promote the phagolysosome formation
and stimulate the lysosomal lipolysis. Only recently, Singh
et al. [23] described direct involvement of autophagy and
lysosomal pathway in the degradation of intracellular lipid
droplets in the liver. They found that lipid droplets can
enter the autophagic degradation pathway in the same
manner as proteins and damaged organelles via formation
of autophago(lipo)somes that further fuses with primary
lysosomes. As the only known lysosomal enzyme with
lipolytic activity is LIPA, we believe that our results are in
accordance with ﬁndings of Singh et al..
The ketone body formation tightly reﬂects the liver
lipid metabolism. Debeer et al. [24] demonstrated that both
ketogenesis and FFA oxidation are a particularly good mark-
ers of lysosomal TAG degradation. We observed higher β-
hydroxybutyrate concentration in serum and higher ketone
body production from isolated liver slices in the absence of
exogenous fatty acids in HFD group. We conclude that these
data provide indirect evidence that conﬁrms the stimulatory
eﬀect of short-term HFD on lysosomal lipolysis.
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Figure 7: The eﬀect of hepatic fat accumulation on PKCε
activation. Representative Western blot is shown in the upper part
of the ﬁgure; TM, total membrane fraction, C, cytosol fraction. The
PKCε membrane to cytosol ratio is shown in the graph. The relative
densities of the bands in the membrane fraction were compared
with corresponding ones in cytosol fraction in order to obtain
the measurable parameter of activation. Values represent means ±
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Concomitantly occurring stimulation of lipolysis and
the accumulation of endogenous TAG after HFD adminis-
tration seem to be contradictory. However, in hepatocytes,
a signiﬁcant portion of FFA released from intracellular
TAG (approximately 70%) is reesteriﬁed back [25]. HFD
impairs VLDL secretion [26], and most of FFA reenter
the intracellular storage pool. We have previously reported
that DGAT-1 expression is increased in fatty liver what
indicatesenhancedesteriﬁcationoffattyacidsandmayresult
in the intensiﬁcation of lipolytic/reesteriﬁcation cycle in
hepatocytes [20]. The increased lipolysis thus does not result
in decreased TAG content but only in higher TAG turnover.
In the liver, PKCε, member of novel PKCs subfamily,
is involved in the development of HFD-induced IR [16,
17]. Samuel et al. showed that fat-induced hepatic IR may
result from activation of PKCε and its downstream targets.
Nevertheless, the nature of the signal that activates PKCε
has not been fully explained. Systemic increase in FFA
serum levels, as one possible underlying factor, has not been
described after HFD administration. Another candidate, 1,2-
sn-DAG, is an important intracellular signalling molecule,
and it is the known activator of novel PKCs isoform family
[27]. The increased DAG content due to the increased ﬂux
throughTAGsyntheticpathwayandthefollowingPKCε acti-
vationwasdescribedinskeletalmuscleinHFD-administered
animals [28]. However, DAG is also an intermediate in TAG
degradation pathway that, in contrast to muscle, is quite
active in the liver. Our ﬁndings suggest that DAG originating
from the increased lipolytic activity of LIPA and accentuated
TAG breakdown could act as PKCε activator in fatty liver.
This hypothesis is supported by the fact that in fatty liver
LIPA is activated speciﬁcally in the fed state, and possible
PKCε activator is available during the period of insulin
action.
In conclusion, we found that short-term HFD-induced
TAG accumulation in the liver is associated with the
increased degradation of intracellular TAG by lysosomal
lipase and with higher production of lipolytic products—
DAG and FFA. Our ﬁndings suggest that the elevated DAG
production by LIPA activated by increased supply of dietary
lipids may represent the causal link between dietary fat-
induced hepatic TAG accumulation and hepatic IR via the
PKCε activation. In the light of these ﬁndings, lysosomal
lipolysis may represent a new promising therapeutic target.
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